Esperion Therapeutics, Inc. (ESPR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
29-May-20 4:38 PM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 6,106----46%
13.29K to 19.39K
29-May-20 4:41 PM
View: 
Gotto Antonio M Jr Md D Phil
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 6,106----123%
4.97K to 11.07K
29-May-20 4:40 PM
View: 
Janney Daniel
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 6,106----21%
29.53K to 35.64K
29-May-20 4:41 PM
View: 
Fuhrman Alan
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 1,221----10%
11.66K to 12.88K
29-May-20 4:39 PM
View: 
McGovern Mark E
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 6,106----61%
9.97K to 16.07K
29-May-20 4:36 PM
View: 
Woody Tracy M
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 6,106----61%
9.93K to 16.04K
29-May-20 4:42 PM
View: 
Berkowitz Jeffrey
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 6,106----123%
4.97K to 11.07K
29-May-20 4:39 PM
View: 
Shepard Jay
Director
Esperion Therapeutics, Inc. (ESPR) 28-May-20Grant 6,106----123%
4.97K to 11.07K
18-May-20 5:04 PM
View: 
Fuhrman Alan
Director
Esperion Therapeutics, Inc. (ESPR) 15-May-20Grant 11,003----1682%
0.65K to 11.66K
12-Mar-20 7:34 AM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 11-Mar-20Private Purchase 2,500$43.00$107,500.002%
109.5K to 112.0K
02-Mar-20 6:16 AM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 28-Feb-20Market Purchase 5,000$49.00$245,000.005%
104.5K to 109.5K
2%
27-Jan-20 12:51 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 23-Jan-20Market Purchase 20,000$52.12$1,042,400.00< 1%
3.73M to 3.75M
(4%)
03-Jan-20 4:27 PM
View: 
Bartram Richard
Chief Financial Officer
Esperion Therapeutics, Inc. (ESPR) 02-Jan-20Grant 7,525----68%
11.15K to 18.67K
03-Jan-20 4:27 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 02-Jan-20Grant 23,150----28%
81.35K to 104.5K
03-Jan-20 4:27 PM
View: 
Glickman Mark A
Chief Commercial Officer
Esperion Therapeutics, Inc. (ESPR) 02-Jan-20Grant 5,925----30%
20.0K to 25.93K
03-Jan-20 4:27 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 15-Nov-19Gift 365----(< 1%)
81.71K to 81.35K
03-Jan-20 4:27 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 11-Nov-19Gift 1,950----(2%)
83.12K to 81.17K
08-Nov-19 4:14 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 06-Nov-19Private Purchase 5,000$36.98$184,900.006%
78.66K to 83.66K
08-Nov-19 2:54 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 06-Nov-19Private Purchase 75,000$37.30$2,797,560.002%
3.65M to 3.73M
06-Sep-19 4:22 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 06-Sep-19Private Purchase 2,500$35.25$88,125.003%
76.16K to 78.66K
06-Sep-19 4:22 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 04-Sep-19Private Purchase 5,000$34.20$170,982.007%
71.16K to 76.16K
06-Sep-19 4:09 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 04-Sep-19Private Purchase 80,000$33.78$2,702,210.002%
3.57M to 3.65M
02-Aug-19 4:06 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 01-Aug-19Private Purchase 5,000$39.56$197,800.008%
66.16K to 71.16K
25-Jul-19 12:42 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 23-Jul-19Private Purchase 50,000$42.65$2,132,560.001%
3.52M to 3.57M
01-Jul-19 4:57 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 28-Jun-19Private Purchase 5,000$46.00$230,000.008%
61.16K to 66.16K
31-May-19 4:52 PM
View: 
Braunstein Scott
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----9552%
52 to 5.02K
31-May-19 4:50 PM
View: 
McGovern Mark E
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----99%
5.0K to 9.97K
31-May-19 4:52 PM
View: 
Woody Tracy M
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 9,934----100%
0 to 9.93K
31-May-19 4:52 PM
View: 
Berkowitz Jeffrey
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----100%
0 to 4.97K
31-May-19 4:50 PM
View: 
Shepard Jay
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----100%
0 to 4.97K
31-May-19 4:51 PM
View: 
Janney Daniel
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----20%
24.57K to 29.53K
31-May-19 4:51 PM
View: 
Gotto Antonio M Jr Md D Phil
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----100%
0 to 4.97K
31-May-19 6:09 PM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 29-May-19Grant 4,967----60%
8.32K to 13.29K
05-Apr-19 5:23 PM
View: 
Bartram Richard
Chief Financial Officer
Esperion Therapeutics, Inc. (ESPR) 03-Apr-19Market Sale (Planned) 8,000$42.88$343,045.00259%
3.09K to 11.09K
(2%)
01-Apr-19 4:41 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 29-Mar-19Market Purchase 5,000$40.00$200,000.009%
56.16K to 61.16K
< 1%
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 21-Mar-19Acquisition (other) 1,356----5%
24.75K to 26.11K
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 21-Mar-19Disposition (other) 17,790----(68%)
26.11K to 8.32K
21-Mar-19 5:01 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 20-Mar-19Market Purchase 5,000$43.48$217,400.0010%
51.16K to 56.16K
< 1%
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 19-Mar-19Acquisition (other) 17,790----2%
1.12M to 1.14M
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 19-Mar-19Disposition (other) 1,101,080----(96%)
1.14M to 40.08K
21-Mar-19 9:02 AM
View: 
Vitullo Nicole
Director
Esperion Therapeutics, Inc. (ESPR) 19-Mar-19Market Sale 15,329$44.73$685,596.00(38%)
40.08K to 24.75K
14-Mar-19 4:57 PM
View: 
Mayleben Timothy M
President & CEO
Director
Esperion Therapeutics, Inc. (ESPR) 14-Mar-19Market Purchase 5,000$48.73$243,650.0011%
46.16K to 51.16K
10%
15-Mar-19 7:50 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 14-Mar-19Market Purchase 50,000$49.89$2,494,360.001%
3.47M to 3.52M
(2%)
14-Mar-19 4:57 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 12-Mar-19Market Sale (Planned) 25,000$50.06$1,251,500.00(4%)
573.73K to 548.73K
(7%)
07-Jan-19 5:10 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 04-Jan-19Market Purchase 80,000$41.29$3,303,260.002%
3.39M to 3.47M
10%
26-Dec-18 11:44 AM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 24-Dec-18Market Purchase 50,000$39.91$1,995,720.001%
3.34M to 3.39M
14%
19-Dec-18 1:14 PM
View: 
Biotech Target N V
10% Owner
Esperion Therapeutics, Inc. (ESPR) 17-Dec-18Market Purchase 60,000$47.73$2,864,070.002%
3.28M to 3.34M
(5%)
05-Nov-18 7:56 PM
View: 
Boxer Capital, LLC
10% Owner
Esperion Therapeutics, Inc. (ESPR) 05-Nov-18Market Sale 60,000$57.16$3,429,840.00(5%)
1.16M to 1.1M
20%
05-Nov-18 7:56 PM
View: 
Boxer Capital, LLC
10% Owner
Esperion Therapeutics, Inc. (ESPR) 02-Nov-18Market Sale 40,000$55.21$2,208,500.00(3%)
1.2M to 1.16M
18%
02-Nov-18 5:00 PM
View: 
Newton Roger S
Director
Esperion Therapeutics, Inc. (ESPR) 02-Nov-18Market Sale (Planned) 227$50.76$11,522.50(< 1%)
573.95K to 573.73K
10%